These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7789393)
21. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. Bernard BF; Krenning EP; Breeman WA; Rolleman EJ; Bakker WH; Visser TJ; Mäcke H; de Jong M J Nucl Med; 1997 Dec; 38(12):1929-33. PubMed ID: 9430472 [TBL] [Abstract][Full Text] [Related]
22. [Detection of intrathoracic infectious lesions using In-diethylenetriamine pentaacetic bicyclic anhydride-IgG (111In-DTPA-IgG) scintigraphy]. Ota T; Goto H; Wada H; Yuasa K; Iguchi M; Okamura T; Ieki R; Suzuki K Kansenshogaku Zasshi; 1998 Feb; 72(2):128-35. PubMed ID: 9545688 [TBL] [Abstract][Full Text] [Related]
23. Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats. Dams ET; Becker MJ; Oyen WJ; Boerman OC; Storm G; Laverman P; de Marie S; van der Meer JW; Bakker-Woudenberg IA; Corstens FH J Nucl Med; 1999 Dec; 40(12):2066-72. PubMed ID: 10616887 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. de Jong M; Rolleman EJ; Bernard BF; Visser TJ; Bakker WH; Breeman WA; Krenning EP J Nucl Med; 1996 Aug; 37(8):1388-92. PubMed ID: 8708781 [TBL] [Abstract][Full Text] [Related]
25. Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody priming. Kranenborg MH; Oyen WJ; Corstens FH; Oosterwijk E; van der Meer JW; Boerman OC J Nucl Med; 1997 Jun; 38(6):901-6. PubMed ID: 9189139 [TBL] [Abstract][Full Text] [Related]
26. Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm. Buijs WC; Oyen WJ; Dams ET; Boerman OC; Siegel JA; Claessens RA; van der Meer JW; Corstens FH Nucl Med Commun; 1998 Aug; 19(8):743-51. PubMed ID: 9751928 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of the hepatocyte uptake of radiolabelled monoclonal antibodies by chelating agents. Davidson BR; Boulos PB; Porter JB Eur J Nucl Med; 1990; 17(6-8):294-8. PubMed ID: 2286201 [TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the usefulness of 111In-DTPA-IgG scintigraphy for the detection of focal inflammatory lesions]. Sasaki M; Ichiya Y; Kuwabara Y; Yoshida T; Fukumura T; Masuda K Kaku Igaku; 1996 Jun; 33(6):669-74. PubMed ID: 8741513 [TBL] [Abstract][Full Text] [Related]
30. Indirect labeling of macroaggregated albumin with indium-111 via diethylenetriaminepentaacetic acid. Watanabe N; Shirakami Y; Tomiyoshi K; Oriuchi N; Hirano T; Yukihiro M; Inoue T; Endo K Nucl Med Biol; 1996 Jul; 23(5):595-8. PubMed ID: 8905824 [TBL] [Abstract][Full Text] [Related]
31. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer. de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332 [TBL] [Abstract][Full Text] [Related]
32. [Biodistribution of low-molecular-weight proteins and technetium (99mTc) labeled peptides in an animal model of inflammation]. Komárek P; Kleisner I; Konopková M; Komárková I Ceska Slov Farm; 2002 Sep; 51(5):252-6. PubMed ID: 12407925 [TBL] [Abstract][Full Text] [Related]
33. 111-indium-DTPA-IgG lung imaging in patients with pulmonary and HIV infection. Khalkhali I; Mena I; Rauh DA; Diggles LE; Pham HL; Mason GR Chest; 1995 May; 107(5):1336-41. PubMed ID: 7750328 [TBL] [Abstract][Full Text] [Related]
34. Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts. Pimm MV; Perkins AC; Baldwin RW Eur J Nucl Med; 1987; 12(10):515-21. PubMed ID: 3569340 [TBL] [Abstract][Full Text] [Related]
35. Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG. Callahan RJ; Barrow SA; Abrams MJ; Rubin RH; Fischman AJ J Nucl Med; 1996 May; 37(5):843-6. PubMed ID: 8965158 [TBL] [Abstract][Full Text] [Related]
36. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody. Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605 [TBL] [Abstract][Full Text] [Related]
37. Easy and efficient (111)indium labeling of long-term stored DTPA conjugated protein. Nalla A; Buch I; Hesse B Curr Radiopharm; 2011 Jan; 4(1):1-4. PubMed ID: 22191609 [TBL] [Abstract][Full Text] [Related]
38. The localization of indium-111-leukocytes, gallium-67-polyclonal IgG and other radioactive agents in acute focal inflammatory lesions. McAfee JG; Gagne G; Subramanian G; Schneider RF J Nucl Med; 1991 Nov; 32(11):2126-31. PubMed ID: 1941149 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P. Breeman WA; VanHagen MP; Visser-Wisselaar HA; van der Pluijm ME; Koper JW; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Hazenberg MP; Lamberts SW; Visser TJ; Krenning EP J Nucl Med; 1996 Jan; 37(1):108-17. PubMed ID: 8543978 [TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Wang S; Luo J; Lantrip DA; Waters DJ; Mathias CJ; Green MA; Fuchs PL; Low PS Bioconjug Chem; 1997; 8(5):673-9. PubMed ID: 9327130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]